Background and objectives: L-carnitine (LC) is a non-protein amino acid includes both diet and endogenous synthesis. There are no studies on the effect of LC on glucose uptake and net glucose output in muscle and hepatic tissues. So, the aim of the present work is to study the metabolic aspects of LC and to study some mechanisms that may be of help in treatment of insulin resistance. Methods: Twenty four male rats were divided into two main groups, twelve rats per each group. In vivo group was divided into control one and L-Carnitine -treated one, It was given in the dose of 3 gm carnitine/kg once every day orally for 4 weeks where fasting serum glucose and plasma free fatty acids (FFA) were measured. In vitro group included experiments on epididymal fat pad (EFP), hemidiaphragm and liver. Results: LC caused a highly significant decrease in fasting plasma FFA level (4.9 ± 1.5 mg/ dl). However, it caused a significant increase in insulin-stimulated glucose uptake by EFP in the presence of supraminimal and supramaximal insulin concentrations (2.5 ± 0.8 and 3.4± 0.4) (mg/ gm wet tissue /hour) and also by hemidiaphragm (4.9 ± 0.3 and 6 ± 0.97) (mg/ gm wet tissue /hour). Also, it increased net glucose output by liver slices in the presence of both insulin concentrations (-4.9 ± 1.1 and -4 ± 1.42) (mg/ gm wet tissue /hour). It decreased FFA release from EFP in the presence of both insulin concentrations (0.5 ± 0.21 and 0.4 ± 0.2 ) (mg/ gm wet tissue /hour), hemidiaphragm (0.5± 0.1 and 0.5 ±0.16) (mg/ gm wet tissue /hour) and liver slices (0.58 ± 0.19 and 0.63± 0.27) (mg/ gm wet tissue /hour). Conclusion: LC increased plasma FFA level. It potentiated the effect of insulin on glucose uptake in EFP and hemidiaphragm. It decreased hepatic insulin sensitivity and responsivity and enhanced the suppressive effect of insulin on FFA release from different peripheral tissues.
INTRODUCTION
L-carnitine (LC) belongs to a group of food factors known as non-nutrient supplements. It is synthesized in the body from the lysine and methionine [1] . Several clinical conditions of LC deficiency have been described, including the genetic deficiency of LC, hemodialysis, muscular and liver disorders, kidney and cardiovascular diseases and diabetes mellitus [2] .
In presence of L-carnitine deficiency, a common feature appears to be the increased serum concentration of triacylglycerol [3] [4] [5] [6] . Therefore, a relevant aspect of the L-carnitine supplementation is a lipid-lowering effect observed in the experimental animals [7] [8] [9] [10] [11] [12] and humans [13] [14] [15] [16] [17] .
On the other hand, diabetes promotes LC deficiency [18, 19] and increased blood triacylglycerol. However, studies investigating the effect of LC supplementation on the blood levels of triacylglycerol in type 1 diabetes are absent. So, the aim of the present work is to clarify:
1) The effect of LC on serum glucose level and plasma FFA level in rats 2) the effect of LC on basal and insulin-stimulated glucose uptake by different tissues 3) the effect of LC on FFA release in presence or absence of insulin in such tissues
MATERIALS AND METHODS

Experimental animals
Twenty four healthy male Sprague Dawley rats, 80 ± 5 days old with average weight of 250 ± 50 grams old were used in the study. Then they were shut of with tightly fitting rubber stopper and placed for one hour in the metabolic shaker at 37° C with a shaking rate of 100 r.p.m.
After incubation was off, the bottles were taken 
Incubation Medium
The incubation medium employed was Krebs Ringer Bicarbonate Buffered Solution (KRBBS).
Measured parameters
Serum glucose level, plasma FFA level, tissue specific glucose uptake and FFA release
Tissues Glucose Uptake
It was calculated as mg per gm wet tissue weight per hour. The glucose uptake was calculated using the following equation:
Glucose uptake = mg per gm wet tissue per hour
Where:
N= Net weight of tissue in Gm V= volume in ml of the incubation medium in the flask (3 ml)
M= difference in the concentration of glucose per 100 ml of the medium between the control and the tissue bottles
Determination of Free Fatty Acids (FFA)
The principal based on the colorimeteric method already described for chloroform solutions of fatty acids.
The method adapted in the present work is that of Dunucomb (1964) . The principal based on the colorimeteric method already described for chloroform solutions of fatty acids.
Statistical analysis:
Values were expressed in the form of mean ( +/-) To test the association between variables correlation co-effeciency test was done.
N.B:
P is significant if lower than or = 0.05 at confidence interval 95 %. The level of significance as the follow: P higher than 0.05 non significant, P lower than 0.05 significant, P lower than 0.01 highly significant, P lower than 0.001 very highly significant
RESULTS
Results are illustrated in tables 1, 2 and 3 and figures 1, 2 and 3 and glucose-6-phosphatase (G6Pase) [27, 28] .
Also, in this study, LC caused a highly significant decrease in plasma FFAs level. This is in agreement with the work of Bieber [29] . This effect could be explained by the effect of LC on improvement of fatty acid oxidation.
We have investigated the direct effects of LC on 
